Q32 Bio (Nasdaq: QTTB) has announced a corporate restructuring, shifting its focus entirely to the development of its lead ...

The Roivant subsidiary Kinevant is to discontinue further development of namilumab for the treatment of sarcoidosis.

Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...

President Donald Trump signed an order Monday imposing global tariffs of 25% on all steel and aluminum imports, likely ...

32% of Mitotech LLC transferred from Rusnano JSC to the Federal Agency for State Property Management. Such changes have occurred in the Unified State Register of Legal Entities according to the ...

In recent company developments, MAIA Biotechnology, Inc., a pharmaceutical preparations company valued at $54.93 million, has ...

Left to their own accord, seeds would drop to the ground in late summer or autumn, survive winter, then germinate when the ...

Roanoke leaders' moves over the past quarter century provided space and other resources for the city's biotechnology sector.

The United States Postal Service announced on Tuesday it will temporarily suspend international package acceptance of inbound ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...